Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;24(6):527-541.
doi: 10.4158/EP-2018-0035. Epub 2018 Apr 6.

EXTERNAL VALIDATION OF THE DIABETES EARLY RE-ADMISSION RISK INDICATOR (DERRI)

EXTERNAL VALIDATION OF THE DIABETES EARLY RE-ADMISSION RISK INDICATOR (DERRI)

Daniel J Rubin et al. Endocr Pract. 2018 Jun.

Abstract

Objective: The Diabetes Early Re-admission Risk Indicator (DERRI) was previously developed and internally validated as a tool to predict the risk of all-cause re-admission within 30 days of discharge (30-day re-admission) of hospitalized patients with diabetes. In this study, the predictive performance of the DERRI with and without additional predictors was assessed in an external sample.

Methods: We conducted a retrospective cohort study of adult patients with diabetes discharged from two academic medical centers between January 1, 2000 and December 31, 2014. We applied the previously developed DERRI, which includes admission laboratory results, sociodemographics, a diagnosis of certain comorbidities, and recent discharge information, and evaluated the effect of adding metabolic indicators on predictive performance using multivariable logistic regression. Total cholesterol and hemoglobin A1c (A1c) were selected based on clinical relevance and univariate association with 30-day re-admission.

Results: Among 105,974 discharges, 19,032 (18.0%) were followed by 30-day re-admission for any cause. The DERRI had a C-statistic of 0.634 for 30-day re-admission. Total cholesterol was the lipid parameter most strongly associated with 30-day re-admission. The DERRI predictors A1c and total cholesterol were significantly associated with 30-day re-admission; however, their addition to the DERRI did not significantly change model performance (C-statistic, 0.643 [95% confidence interval, 0.638 to 0.647]; P = .92).

Conclusion: Performance of the DERRI in this external cohort was modest but comparable to other re-admission prediction models. Addition of A1c and total cholesterol to the DERRI did not significantly improve performance. Although the DERRI may be useful to direct resources toward diabetes patients at higher risk, better prediction is needed.

Abbreviations: A1c = hemoglobin A1c; CI = confidence interval; DERRI = Diabetes Early Re-admission Risk Indicator; GEE = generalized estimating equation; HDL-C = high-density-lipoprotein cholesterol; ICD-9-CM = International Classification of Diseases, Ninth Revision, Clinical Modification; LDL-C = low-density-lipoprotein cholesterol.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

The authors have no multiplicity of interest to disclose.

Figures

Fig. 1.
Fig. 1.
(A) Receiver operating characteristic (ROC) curves of all-cause 30-day re-admission predicted by the Diabetes Early Re-admission Risk Indicator (DERRI™) in internal and external validation samples. (B) ROC curves of all-cause 30-day re-admission predicted by the DERRI™ and DERRI™ plus hemoglobin A1c and total cholesterol in external validation sample.
Fig. 1.
Fig. 1.
(A) Receiver operating characteristic (ROC) curves of all-cause 30-day re-admission predicted by the Diabetes Early Re-admission Risk Indicator (DERRI™) in internal and external validation samples. (B) ROC curves of all-cause 30-day re-admission predicted by the DERRI™ and DERRI™ plus hemoglobin A1c and total cholesterol in external validation sample.
Fig. 2.
Fig. 2.
(A) Quintiles of all-cause 30-day re-admission risk predicted by the Diabetes Early Re-admission Risk Indicator (DERRI™) in internal and external validation samples. (B) Quintiles of all-cause 30-day re-admission risk predicted by the DERRI™ and DERRI™ plus hemoglobin A1c and total cholesterol in external validation sample.
Fig. 2.
Fig. 2.
(A) Quintiles of all-cause 30-day re-admission risk predicted by the Diabetes Early Re-admission Risk Indicator (DERRI™) in internal and external validation samples. (B) Quintiles of all-cause 30-day re-admission risk predicted by the DERRI™ and DERRI™ plus hemoglobin A1c and total cholesterol in external validation sample.

Similar articles

Cited by

References

    1. Axon RN, Williams MV. Hospital readmission as an accountability measure. JAMA. 2011;305:504–505. - PubMed
    1. Stone J, Hoffman G Medicare Hospital Readmissions: Issues, Policy Options and PPACA. Congressional Research Service; Penny Hill Press; 2010.
    1. Epstein AM. Revisiting readmissions--changing the incentives for shared accountability. N Engl J Med. 2009;360:1457–1459. - PubMed
    1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–1046. - PMC - PubMed
    1. Robbins JM, Webb DA. Diagnosing diabetes and preventing rehospitalizations: the urban diabetes study. Med Care. 2006;44:292–296. - PMC - PubMed

Publication types

  NODES
Association 3
INTERN 6
twitter 2